Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-03

FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for albuterol sulfate from Sandoz Inc, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol sulfate (Albuterol sulfate)

Snippet

SUPPL AP for ALBUTEROL SULFATE (ALBUTEROL SULFATE)